Bioelectric Medical Pioneers Parasym™ Launch Nurosym™

With over 1 million people in the UK suffering from long term COVID symptoms, Parasym has harnessed the effectiveness of neurotechnology to develop Nurosym™, a non-invasive device shown to reverse long COVID symptoms in a recent clinical trial.

Using neuromodulation, the first of its kind device works by targeting micropulses of electrical current to the vagus nerve, without penetrating the skin. Supported by over 20 years of clinical research into the effectiveness of stimulating the vagus nerve, Nurosym™ has been clinically shown to positively improve numerous mental and physical conditions, such as long COVID, depression, fatigue, and cognitive issues. Furthermore, scientific research supports the benefits of vagus nerve stimulation in reversing signs of aging and enhancing sleep quality.

In a study conducted at the Human Waves Clinic and Université Libre de Bruxelles, the Nurosym™ showed a “very significant improvement” for long COVID symptoms including chronic fatigue, brain fog, body aches, and shortness of breath, in only 10 days due to a targeted autonomic reset.




Nurosym™ is a game-changer compared to pharmacological interventions, with the non-invasive treatment offering similar results to medication with no dangerous side effects.

Using an earpiece that looks like a headphone, connected to a rechargeable control unit, the portable device sends small targeted micropulses of electrical current at specific parameter combinations to the vagus nerve which then projects to the brain and major organs in the body. For optimum results, it is recommended to use the device for one hour per day, with health benefits being obtained in as little as 10 days.



Dr Elisabetta Burchi, clinical psychiatrist and head of translational research at Parasym commented:

“Bioelectric medicine is one of the most exciting new fields in modern science, and we are excited to be at the forefront of innovation and research into neuromodulation. Often in the field of neuroscience and particularly in neuromodulation, the gap between research and clinical application is significant. With Nurosym we have been able to translate years of research and development into a user-centric product to significantly improve lives.”

Over the past 18 months, many people have been impacted by the effects of COVID-19 with millions of individuals who have had COVID-19 continuing to experience symptoms months after their initial diagnosis. Nurosym™️ provides an innovative solution to help people living with long COVID to return to their normal lives.

Available to purchase from for £599, the Nurosym™ utilises advances in electroceutical technology to provide ground-breaking treatment for numerous health and wellness conditions ranging from mental to physical, without the need for medication.